| # | Drug | Count |
|---|---|---|
| 0 | OMEPRAZOLE MAGNESIUM | 15 |
| 1 | PREDNISOLONE | 15 |
| 2 | PREDNISOLONE ORAL | 15 |
| 3 | PREDNISOLONE ORAL SOLUTION | 15 |
| 4 | DOXYCYCLINE | 14 |
| 5 | DOXYCYCLINE HYCLATE | 14 |
| 6 | OMEPRAZOLE | 14 |
| 7 | ALBUTEROL | 13 |
| 8 | ALBUTEROL SULFATE | 13 |
| 9 | ASPIRIN | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BUPIVACAINE AND MELOXICAM | 1 | 0.0047 |
| 1 | MIRIKIZUMAB-MRKZ | 1 | 0.0011 |
| 2 | ALDESLEUKIN | 1 | 0.0008 |
| 3 | DOXYCYCLINE MONOHYDRATE | 1 | 0.0006 |
| 4 | MINOCYCLINE | 7 | 0.0006 |
| 5 | MINOCYCLINE HYDROCHLORIDE | 2 | 0.0003 |
| 6 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 7 | NIFEDIPINE | 10 | 0.0002 |
| 8 | CAPTOPRIL | 2 | 0.0002 |
| 9 | DOXYCYCLINE HYCLATE | 14 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 22 |
| 1 | Corticosteroid [EPC] | 19 |
| 2 | Tetracycline-class Drug [EPC] | 15 |
| 3 | Proton Pump Inhibitor [EPC] | 14 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 13 |
| 5 | Dihydropyridine Calcium Channel Blocker [EPC] | 10 |
| 6 | Interferon beta [EPC] | 9 |
| 7 | Benzodiazepine [EPC] | 7 |
| 8 | Purine Antimetabolite [EPC] | 4 |
| 9 | Aminosalicylate [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 1 | Tetracycline-class Drug [EPC] | 15 | 0.0002 |
| 2 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 2 | 0.0001 |
| 3 | Interferon beta [EPC] | 9 | 0.0000 |
| 4 | Purine Antimetabolite [EPC] | 4 | 0.0000 |
| 5 | Dihydropyridine Calcium Channel Blocker [EPC] | 10 | 0.0000 |
| 6 | Aminosalicylate [EPC] | 3 | 0.0000 |
| 7 | Proton Pump Inhibitor [EPC] | 14 | 0.0000 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 13 | 0.0000 |
| 9 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |